About Epitel
Epitel is a digital health company dedicated to modernizing brain health solutions, with a primary focus on improving seizure monitoring and detection. The company leverages a proprietary cloud-based wearable sensor system combined with innovative artificial intelligence (AI) technologies to offer accessible, affordable, and reliable electrographic seizure detection. Their flagship product, the REMI™ Remote EEG Monitoring System, received initial FDA clearance in 2021 for use in hospital emergency rooms and critical care units.
Further FDA clearances have expanded the REMI system’s indications for use to include ambulatory (at-home) settings and for pediatric patients as young as one year old. Epitel has also developed AI-powered modules like REMI Vigilenz™ AI for Event Detection and REMI Vigilenz™ AI For Bedside Notifications, which analyze EEG records in near real-time to identify potential electrographic seizures and provide confidence levels. These advancements aim to empower physicians, caregivers, and patients by enabling better-informed treatment decisions and improving outcomes, particularly in healthcare settings that may lack 24/7 EEG coverage or specialized technicians.
Focus Areas
Business Intelligence
| Key Investors | Catalyst Health Ventures (CHV), Genoa Ventures, Dexcom, OSF Ventures, Wavemaker 360, MedMountain Ventures, Salt Lake City Angels, Southwest National Pediatric Device Innovation Consortium, Angel Physicians Fund, NIH, Epilepsy Foundation |
| Technology | Cloud-based wearable sensor system, AI technologies, wireless EEG monitoring platform, machine learning for seizure detection |
| FDA Clearances | 5 cleared products (estimated) |
What Physicians Need to Know
Epitel's REMIu2122 system offers physicians a transformative tool for brain health monitoring. Its **wearable, wireless EEG technology** (REMIu2122 Remote EEG Monitoring System) significantly improves access to crucial EEG data, moving monitoring from large tertiary hospitals to community hospitals, emergency departments, ICUs, and even patients' homes. The **simplified application process**, requiring no specialized EEG technician, means rapid deployment and initiation of monitoring within minutes, which is vital in neurological emergencies. The **REMI Vigilenzu2122 AI for Event Detection** acts as a powerful triage tool, analyzing extended-duration EEG recordings and flagging potential electrographic seizures with high sensitivity (up to 100% for all seizures in some studies, and 86.2% event-level sensitivity in a clinical validation study), dramatically reducing the time neurologists spend reviewing uneventful data. This allows for more efficient and effective treatment decisions. Furthermore, the system is **FDA cleared for both in-facility and ambulatory use** and is **reimbursable using preexisting codes**, easing adoption into existing clinical workflows and potentially lowering overall healthcare costs by reducing hospital length of stay and unnecessary medication use.
Epitel's REMIu2122 system is built around a proprietary cloud-based wearable sensor system. The REMI Mobile application runs on qualified commercial off-the-shelf mobile computing platforms, receiving and transmitting data from REMI Sensors to the secure REMI Cloud. This data is then prepared for review on qualified EEG viewing software. The system is designed to integrate into existing physician and hospital workflows, supporting a seamless transition for seizure patients from hospital to home.
What the Web Says
Epitel is a digital health company that has developed the REMI Wireless Wearable EEG system for seizure monitoring and detection, receiving FDA clearance for various age groups, including children as young as one year old. The company is generally viewed positively by employees, who highlight a mission-oriented culture, opportunities for growth, and transparent leadership. Product reviews suggest that while the REMI system offers significant advantages in terms of portability and ease of use for long-term, unobtrusive monitoring, some users on Reddit have noted drawbacks with device dependability and strap design for young children.
Overall: PositiveStrengths
- Meaningful work and profound impact on healthcare.
- Transparent goals and strong communication from leadership.
- Opportunities for career growth and exposure to innovative biotech projects.
- REMI system is wireless, easy to use, and allows patients to move freely.
- REMI system provides accurate high-fidelity EEG recordings and rapid monitoring.
- Automated seizure detection software improves accuracy.
Limitations
- Occasional device battery issues and unreliability reported by some users.
- Proprietary strap design for the REMI system can be difficult to put on for children and is not compatible with third-party straps.
- Customer service for the product has been described as mixed, with potential delays in technical issue resolution.
- Some features of the REMI system may be limiting for very specific needs, and advanced customization might be restricted.
- False positive alarms and high false-negative rates have been an issue for some wearable epilepsy devices, leading to users ignoring alerts.
- The average annual salary at Epitel Inc. is an estimation and not from factual payroll records.
Based on reviews from: G2, Glassdoor, Reddit, Indeed.com, Neurology Today, Business Wire, Epilepsia (via PMC), Epitel, Inc. (company website)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Epitel.
Videos load interactively. If none appear, search YouTube for Epitel →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Epitel.
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]
Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]
Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]